title: CPT-11-induced cholinergic effects in cancer patients.
authors.forename: D
authors.initials: D
authors.lastname: Gandia
authors.forename: D
authors.initials: D
authors.lastname: Abigerges
authors.forename: J P
authors.initials: JP
authors.lastname: Armand
authors.forename: G
authors.initials: G
authors.lastname: Chabot
authors.forename: L
authors.initials: L
authors.lastname: Da Costa
authors.forename: M
authors.initials: M
authors.lastname: De Forni
authors.forename: A
authors.initials: A
authors.lastname: Mathieu-Boue
authors.forename: P
authors.initials: P
authors.lastname: Herait
mesh_terms: D000972:Antineoplastic Agents, Phytogenic / Q000009:adverse effects*; D002166:Camptothecin / Q000009:adverse effects / Q000031:analogs & derivatives*; D006801:Humans; D000077146:Irinotecan; D010277:Parasympathomimetics / Q000009:adverse effects*
chemical_list: D000972:Antineoplastic Agents, Phytogenic; D010277:Parasympathomimetics; D000077146:Irinotecan; D002166:Camptothecin